Evidence map›Paper›PMID 27466362›Full record

ArticleThe Journal of biological chemistry2016

Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival.

Yi Liao, Hsueh-Ping Chu, Zhixian Hu, Jason J Merkin, Jianmin Chen, Zuguo Liu, Kurt Degenhardt, Eileen White, Alexey G Ryazanov

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi LiaoFrom the Eye Institute of Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, China, the Department of Pharmacology, Robert Wood Johnson Medical School, and.
Hsueh-Ping Chuthe Department of Pharmacology, Robert Wood Johnson Medical School, and the Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, Boston, Massachusetts 02114.
Zhixian Huthe Department of Pharmacology, Robert Wood Johnson Medical School, and.
Jason J Merkinthe Department of Pharmacology, Robert Wood Johnson Medical School, and.
Jianmin Chenthe Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854.
Zuguo LiuFrom the Eye Institute of Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Xiamen, Fujian 361102, China, the Affiliated Xiamen Eye Center of Xiamen University, Xiamen, Fujian 361102, China.
Kurt Degenhardtthe Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, and.
Eileen Whitethe Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, and.
Alexey G Ryazanovthe Department of Pharmacology, Robert Wood Johnson Medical School, and ryazanag@rwjms.rutgers.edu.

Funding

THE ROLE OF PROTEIN TURNOVER IN AGINGR01AG019890 · NIA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 2001 to 2005
$1.9M
Development of New Drugs that Protect Gastrointestinal Tract from RadiationRC1AI078513 · NIAID · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 2007 to 2009
$1.1M
STRUCTURE/FUNCTION OF EFF-2 KINASER01GM057300 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 1999 to 2003
$1.0M
THE ROLE OF EF-2 KINASE IN DRUG RESISTANCER01CA081102 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 2000 to 2003
$932k
Investigation of synergism between mTOR and eEF2 kinase pathwaysR21AG042870 · NIA · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 2012 to 2013
$425k
Translational Control of Radiation-Induced ApoptosisR03TW008217 · FIC · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI RYAZANOV, ALEXEY G. · 2010 to 2012
$169k
FIC NIH HHS R03 TW008217NCI NIH HHS R01 CA081102NIAID NIH HHS RC1 AI078513NIA NIH HHS R01 AG019890NIA NIH HHS R21 AG042870NIGMS NIH HHS R01 GM057300
6 · The paper itself

Abstract

Protein synthesis inhibition is an immediate response during stress to switch the composition of protein pool in order to adapt to the new environment. It was reported that this response could be either protective or deleterious. However, how cells choose to live or die upon protein synthesis inhibition is largely unknown. Previously, we have shown that elongation factor-2 kinase (eEF2K), a protein kinase that suppresses protein synthesis during elongation phase, is a positive regulator of apoptosis both in vivo and in vitro Consistently, here we report that knock-out of eEF2K protects mice from a lethal dose of whole-body ionizing radiation at 8 Gy by reducing apoptosis levels in both bone marrow and gastrointestinal tracts. Surprisingly, similar to the loss of p53, eEF2K deficiency results in more severe damage to the gastrointestinal tract at 20 Gy with the increased mitotic cell death in small intestinal stem cells. Furthermore, using epithelial cell lines, we showed that eEF2K is required for G2/M arrest induced by radiation to prevent mitotic catastrophe in a p53-independent manner. Specifically, we observed the elevation of Akt/ERK activity as well as the reduction of p21 expression in Eef2k(-/-) cells. Therefore, eEF2K also provides a protective strategy to maintain genomic integrity by arresting cell cycle in response to stress. Our results suggest that protective versus pro-apoptotic roles of eEF2K depend on the type of cells: eEF2K is protective in highly proliferative cells, such as small intestinal stem cells and cancer cells, which are more susceptible to mitotic catastrophe.

Indexed as

Elongation Factor 2 KinaseIntestine, SmallMitosisRadiation Injuries, ExperimentalRadiation ToleranceStem CellsAnimalsApoptosisCell SurvivalGamma RaysMiceMice, KnockoutTumor Suppressor Protein p53Eef2k protein, mouseElongation Factor 2 KinaseTumor Suppressor Protein p53apoptosiscell cyclecell deatheukaryotic elongation factor-2 kinase (eEF2K)mitotic catastropheradiation biologystem cells

Identifiers

PMID27466362
PMCPMC5016690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.